Development
Cardinal Health, Inc.
CAH
$165.10
-$0.305-0.18%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 11.99% | 12.39% | 13.04% | 12.34% | 12.68% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.99% | 12.39% | 13.04% | 12.34% | 12.68% |
| Cost of Revenue | 12.05% | 12.55% | 13.33% | 12.65% | 13.18% |
| Gross Profit | 10.09% | 8.07% | 5.26% | 3.93% | 0.29% |
| SG&A Expenses | 5.26% | 4.18% | 6.08% | 4.22% | 3.68% |
| Depreciation & Amortization | -12.34% | -12.03% | -12.04% | -11.66% | -17.87% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 11.85% | 12.30% | 13.10% | 12.39% | 12.85% |
| Operating Income | 28.81% | 23.70% | 6.37% | 6.55% | -4.83% |
| Income Before Tax | 688.02% | 148.83% | 182.96% | 178.62% | -326.67% |
| Income Tax Expenses | -54.81% | 430.77% | 130.67% | -92.77% | 279.70% |
| Earnings from Continuing Operations | 150.39% | 114.36% | 128.11% | 148.74% | -328.78% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -100.00% | 0.00% | 0.00% | -100.00% | 0.00% |
| Net Income | 150.20% | 114.26% | 127.97% | 148.48% | -329.37% |
| EBIT | 28.81% | 23.70% | 6.37% | 6.55% | -4.83% |
| EBITDA | 19.81% | 16.31% | 4.50% | 4.61% | -3.80% |
| EPS Basic | 155.04% | 115.55% | 129.23% | 149.77% | -340.99% |
| Normalized Basic EPS | 49.40% | 42.64% | 20.59% | 13.76% | -1.11% |
| EPS Diluted | 154.54% | 115.26% | 128.69% | 149.17% | -343.64% |
| Normalized Diluted EPS | 49.28% | 42.90% | 20.75% | 13.73% | -0.69% |
| Average Basic Shares Outstanding | -7.04% | -7.10% | -6.46% | -6.19% | -5.92% |
| Average Diluted Shares Outstanding | -7.01% | -7.34% | -6.61% | -6.24% | -6.31% |
| Dividend Per Share | 1.41% | 1.41% | 1.41% | 0.59% | 0.59% |
| Payout Ratio | 2.87% | 7.53% | 4.36% | 2.94% | -1.41% |